Orchid Pharma Ltd
NSE:ORCHPHARMA

Watchlist Manager
Orchid Pharma Ltd Logo
Orchid Pharma Ltd
NSE:ORCHPHARMA
Watchlist
Price: 1 797.4 INR 4.1%
Market Cap: 91.2B INR
Have any thoughts about
Orchid Pharma Ltd?
Write Note

Orchid Pharma Ltd
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Orchid Pharma Ltd
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Orchid Pharma Ltd
NSE:ORCHPHARMA
Cash Interest Paid
â‚ą163.5m
CAGR 3-Years
-26%
CAGR 5-Years
122%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash Interest Paid
â‚ą2.9B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash Interest Paid
â‚ą442.1m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash Interest Paid
â‚ą2.2B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash Interest Paid
â‚ą3.1B
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Cash Interest Paid
â‚ą261.7m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Orchid Pharma Ltd
Glance View

Market Cap
91.2B INR
Industry
Pharmaceuticals

Orchid Pharma Ltd. engages in the development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company is headquartered in Chennai, Tamil Nadu. The firm is involved in the development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals. The company has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. The company offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.

ORCHPHARMA Intrinsic Value
1 261.31 INR
Overvaluation 30%
Intrinsic Value
Price

See Also

What is Orchid Pharma Ltd's Cash Interest Paid?
Cash Interest Paid
163.5m INR

Based on the financial report for Mar 31, 2024, Orchid Pharma Ltd's Cash Interest Paid amounts to 163.5m INR.

What is Orchid Pharma Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
122%

Over the last year, the Cash Interest Paid growth was -49%. The average annual Cash Interest Paid growth rates for Orchid Pharma Ltd have been -26% over the past three years , 122% over the past five years .

Back to Top